These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9645916)

  • 41. Laboratory measures of hemostasis for monitoring liver graft function.
    Moia M; Martinelli I; Mannucci PM
    Semin Thromb Hemost; 1993; 19(3):238-42. PubMed ID: 8362254
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory diagnosis of bleeding disorders. Basic screening tests.
    Palmer RL
    Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use.
    Harrison RL; Alperin JB; Kumar D
    Arch Pathol Lab Med; 1987 Aug; 111(8):719-22. PubMed ID: 3115223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 45. Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
    Tripodi A; Poggio M; Scapellato L; Mannucci PM
    Haemostasis; 1989; 19(4):205-12. PubMed ID: 2509308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). A clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma.
    Doellgast GJ; Triscott MX; Buss DH; West J
    Clin Chem; 1988 Feb; 34(2):294-9. PubMed ID: 2830053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient.
    Ciavarella D; Reed RL; Counts RB; Baron L; Pavlin E; Heimbach DM; Carrico CJ
    Br J Haematol; 1987 Nov; 67(3):365-8. PubMed ID: 3689699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. THE FIBROMETER SYSTEM FOR ROUTINE COAGULATION TESTS: PROTHROMBIN TIME AND PARTIAL THROMBOPLASTIN TIME, MACRO AND MICRO.
    MIALE JB
    Am J Clin Pathol; 1965 May; 43():475-80. PubMed ID: 14287798
    [No Abstract]   [Full Text] [Related]  

  • 49. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 50. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
    Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Hornykewycz S; Michitsch A; Huber K; Clemens D; Susan M; Pabinger I; Eichinger S; Jilma B; Speiser W
    Thromb Res; 1997 Sep; 87(5):431-40. PubMed ID: 9306617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Parietal thromboplastin time, thromboplastin time fibrinogen, thrombin time and thrombocyte count in healthy and sick newborn infants].
    Göbel U; Riech P
    Monatsschr Kinderheilkd (1902); 1972 Dec; 120(12):484-8. PubMed ID: 4646962
    [No Abstract]   [Full Text] [Related]  

  • 54. Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it?
    Dumoulin EN; Fiers L; Devreese KM
    Clin Chem Lab Med; 2016 May; 54(5):e169-72. PubMed ID: 26587744
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies of platelet factor-3 by the kaolin clotting time and thromboplastin generation time].
    Oki H; Takashima A
    Rinsho Byori; 1973 Jul; 21(7):621-6. PubMed ID: 4738067
    [No Abstract]   [Full Text] [Related]  

  • 57. Coagulation of flowing native blood: advantages over stagnant (tube) clotting tests.
    Görög P; Kovacs IB
    Thromb Res; 1991 Dec; 64(5):611-9. PubMed ID: 1808765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic.
    McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ
    Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734
    [No Abstract]   [Full Text] [Related]  

  • 59. [BLOOD CLOTTING FACTORS IN RENAL DISEASES].
    SATAKE K
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():767-78. PubMed ID: 14154694
    [No Abstract]   [Full Text] [Related]  

  • 60. Coagulation studies in leptospirosis.
    Jaroonvesama N; Viranuvatti V; Charoenlarp K
    Southeast Asian J Trop Med Public Health; 1975 Dec; 6(4):562-6. PubMed ID: 1084021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.